According to our latest research, the cholesterol testing product & services market size reached USD 13.2 billion globally in 2024, driven by the increasing prevalence of cardiovascular diseases and heightened awareness about preventive healthcare. The market is expanding at a steady CAGR of 6.1% and is projected to attain a value of approximately USD 22.3 billion by 2033. This robust growth is primarily attributed to the rising adoption of advanced cholesterol testing technologies, growing demand for point-of-care testing solutions, and supportive government initiatives focused on early disease detection and management.
https://growthmarketreports.co....m/report/cholesterol
Curtir
Comentario
Compartilhar
